Mr Josh E Mcwilliams, MD | |
700 S Telephone Road, Moore, OK 73160 | |
(405) 793-9355 | |
Not Available |
Full Name | Mr Josh E Mcwilliams |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 25 Years |
Location | 700 S Telephone Road, Moore, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366490088 | NPI | - | NPPES |
200029960A | Medicaid | OK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PE0004X | Emergency Medicine - Emergency Medical Services | 23717 (Oklahoma) | Primary |
207P00000X | Emergency Medicine | 23717 (Oklahoma) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Community Hospital, Llc | Oklahoma city, OK | Hospital |
Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Hospital Llc | 2466494646 | 2 |
Rylan-jagger Medical Llc | 0244300127 | 2 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Entity Name | Community Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275593337 PECOS PAC ID: 2466494646 Enrollment ID: O20050527000098 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Entity Name | Tpg Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942260971 PECOS PAC ID: 8729990544 Enrollment ID: O20060209000149 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Entity Name | Rylan-jagger Medical Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316127913 PECOS PAC ID: 0244300127 Enrollment ID: O20080604000218 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Entity Name | Hpi Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205152600 PECOS PAC ID: 6406048289 Enrollment ID: O20101012000705 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Entity Name | Emergency Services Of Oklahoma Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215249891 PECOS PAC ID: 8123209012 Enrollment ID: O20110225000085 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Entity Name | Emergency Physicians Of Mid-america Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063825297 PECOS PAC ID: 2062638661 Enrollment ID: O20140716001692 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Josh E Mcwilliams, MD 2516 Mission Rd, Edmond, OK 73034-6868 Ph: () - | Mr Josh E Mcwilliams, MD 700 S Telephone Road, Moore, OK 73160 Ph: (405) 793-9355 |
News Archive
People who later develop Parkinson's disease have an increased tendency to fall and injure themselves, being at particular risk of hip fracture, a study shows.
Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February.
Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics.
Salk Professor Kay Tye has been selected as a Howard Hughes Medical Institute (HHMI) investigator, joining a prestigious group of more than 250 HHMI investigators across the United States who are tackling important scientific questions.
› Verified 5 days ago
Harold Nathanial Claver, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Wesley Cir, Moore, OK 73160 Phone: 918-520-6854 | |
Dr. Corey D Finch Sr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 507 Ne 12th St, Moore, OK 73160 Phone: 405-237-9955 | |
Dr. Bob Joe Schank, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 Sw 34th St Ste 200, Moore, OK 73160 Phone: 405-793-1188 Fax: 405-793-0492 | |
Dr. Jessica Dawn Hildebrand, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 S Telephone Rd Ste 250, Moore, OK 73160 Phone: 405-237-7500 | |
Mr. Michael Padgham, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Telephone Road, Moore, OK 73160 Phone: 405-793-9355 | |
Ms. Angela Selmon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Telephone Road, Moore, OK 73160 Phone: 405-793-9355 |